+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Advanced Gastric Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Cell Wall Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cell Wall Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Renal Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Collagen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Collagen Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Myeloid Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Myeloid Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
Cervical Cancer - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
Ocular Melanoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Ocular Melanoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 71 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
Checkpoint Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Mucinous Cystic Neoplasms (MCNs) - Pipeline Insight, 2025 - Product Thumbnail Image

Mucinous Cystic Neoplasms (MCNs) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
C-Raf Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

C-Raf Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more